retatrutide clinical trial results Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP retatrutide triple hormone receptor agonist

Metformins gastrointestinal effects predominantly involve diarrhea, bloating, and metallic taste

In addition, reduced appetite may result in lower intake of essential nutrients such as calcium, vitamin D, and protein

February 20, 2025

This suggests that drug interactions or the physiological stress of infection treatment may contribute to allodynia development or recurrence

What emerges is a coherent biological framework: estrogen maintains the mitochondrial infrastructure and synaptic stability that neurons depend on for sustained function, while GLP-1 receptor activation reduces the inflammatory burden that progressively degrades that infrastructure